DailyDoctor Archive Specialties Get app
Back to the 13 September 2026 edition

Clinical update · 04 of 06

Anxiety and depression in inflammatory bowel disease may be part of the disease, not a reaction to it

In inflammatory bowel disease with new anxiety or depression, establish what the disease is doing before you decide what the mood symptoms are.

A review of the gut-brain axis in inflammatory bowel disease sets out the mechanisms by which neuropsychiatric comorbidity arises: neural, endocrine and immune signalling between gut and brain, disrupted by microbiota imbalance, intestinal barrier damage, neuroinflammation with immune activation, and neuroendocrine abnormalities. The argument is that anxiety, depression and other neurological manifestations in these patients are secondary conditions produced by impaired gut-brain communication rather than purely psychological responses to living with a chronic illness.

This is a mechanistic review and it does not deliver a treatment. What it changes is the framing at the point of referral. A gastroenterologist who sends a patient with Crohn's disease and new low mood is often implicitly asking for help with coping; the pathophysiological account suggests the first question should instead be what the bowel is doing. Depression that tracks disease activity is a different clinical problem from depression that persists in remission, and the two warrant different responses.

In practice this means asking about disease activity, recent flares, steroid exposure and current biologic therapy before settling on a formulation. It also means not deferring psychiatric treatment on the assumption that the mood will lift when the bowel settles - the review's position is that these are genuine comorbidities, not epiphenomena.

  • Ask about current disease activity and recent flares before formulating new low mood in inflammatory bowel disease
  • Record steroid exposure explicitly; it confounds both the mood and the inflammatory picture
  • Distinguish mood symptoms that track flares from those persisting in remission - they behave differently
  • Do not defer antidepressant treatment on the expectation that gut remission will resolve it
  • Liaise with the gastroenterology team rather than treating the referral as a request for coping support

Why it matters

It reframes a referral usually read as a request for coping support into a question about disease activity.

Don't overread it

A mechanistic review - it proposes pathways rather than establishing that treating them changes mood.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

depressionanxietyaddiction

Tomorrow morning, before your first patient

One edition a day for psychiatry, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app